Search results
AbbVie Inc. (NYSE:ABBV) Holdings Cut by Carolina Wealth Advisors LLC
ETF DAILY NEWS· 2 days agoCarolina Wealth Advisors LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% during the 1st quarter, according to its most recent filing ...
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 2 days agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
Pensionfund Sabic Sells 3,100 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoPensionfund Sabic lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 15.7% during the first quarter, according to the company in its most recent Form 13F filing ...
Scarborough Advisors LLC Takes $1.38 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoScarborough Advisors LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 8,907 shares of ...
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 3 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Tri-County Times· 4 days agoAbbVie logo (PRNewsFoto/AbbVie)
2 Dividend Stocks That Could Pay You for Life | The Motley Fool
The Motley Fool· 6 days agoPeople invest in dividend stocks for various reasons. Let's consider two examples: AbbVie (ABBV...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks· 5 days agoFree Report) ending at $171.36, denoting a +0.99% adjustment from its last day's close. This change outpaced the S&P 500's 0.25% gain on the day. In that same time, the Medical sector gained ...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 4 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...